Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
K100831Substantially Equivalent

Cyfra 21-1 Eia Model 211-10

Fujirebio Diagnostics, Inc., Malvern PA / Traditional, Substantially Equivalent

K100831 is the FDA 510(k) clearance record for CYFRA 21-1 EIA MODEL 211-10, a class II device, cleared for Fujirebio Diagnostics,Inc. on under FDA product code OVK (Cytokeratin Fragments 21-1 Eia Kit). FDA's definition for product code OVK reads: "The CYFRA 21-1 EIA kit is intended for the quantitative determination of soluble cytokeratin 19 fragments in human serum. The assay is to be used as an aid in monitoring disease progression during the course of disease and treatment in...". FDA records list 45 510(k) clearances for Fujirebio Diagnostics,Inc., from to . As of , FDA records show no recalls naming K100831.

Clearance record

Decision date
Received
(428 days to decision)
Product code
OVK Cytokeratin Fragments 21-1 Eia Kit
Regulation
21 CFR 866.6010
Device class
Class II
Review panel
Immunology
Applicant
Fujirebio Diagnostics,Inc. 201 Great Valley Pkwy., Malvern PA
510(k) summary
Summary PDF
Third party review
No

Clearances, product code OVK

Trailing 12 months
1 clearance under product code OVK in the twelve months to October 2026, December 2025 the highest month at 1.
Show the numbers
Monthly 510(k) clearances under FDA product code OVK, trailing twelve months
MonthClearances
November 20250
December 20251
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260